NCT06605625View on ClinicalTrials.gov

Vaccine Responses in Cancer

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 4, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Viral Vaccines
Interventions
BIOLOGICAL

Influenza vaccination

one annual dose of inactivated influenza vaccine

BIOLOGICAL

SARS-CoV-2 vaccine

dose of SARS CoV2 vaccine

BIOLOGICAL

Zoster Vaccine Recombinant

first and/or second vaccination for shingles (Herpes zoster)

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER